Quick filters:
Levodopa Stock Photos and Images
Co-Beneldopa (Levodopa / Benserazide) capsules for treating Parkinson's disease Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-co-beneldopa-levodopa-benserazide-capsules-for-treating-parkinsons-38606610.htmlRMC6PK3E–Co-Beneldopa (Levodopa / Benserazide) capsules for treating Parkinson's disease
RIO DE JANEIRO, BRAZIL - MARCH 18, 2021: Parkinson's disease medicine (Prolopa - Levodopa + Cloridrato de Benserazida) Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/rio-de-janeiro-brazil-march-18-2021-parkinsons-disease-medicine-prolopa-levodopa-cloridrato-de-benserazida-image467750400.htmlRF2J4YTBC–RIO DE JANEIRO, BRAZIL - MARCH 18, 2021: Parkinson's disease medicine (Prolopa - Levodopa + Cloridrato de Benserazida)
Levodopa (L-DOPA) Parkinson's disease drug molecular model L-DOPA is a precursor of the catecholamine neurotransmitters Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/levodopa-l-dopa-parkinsons-disease-drug-molecular-model-l-dopa-is-image69886287.htmlRFE1KGJR–Levodopa (L-DOPA) Parkinson's disease drug molecular model L-DOPA is a precursor of the catecholamine neurotransmitters
Chemical formula, skeletal formula and 3D ball-and-stick model of l-DOPA, also known as levodopa and l-3,4-dihydroxyphenylalanine, white background Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/chemical-formula-skeletal-formula-and-3d-ball-and-stick-model-of-l-dopa-also-known-as-levodopa-and-l-34-dihydroxyphenylalanine-white-background-image449160146.htmlRF2H2N09P–Chemical formula, skeletal formula and 3D ball-and-stick model of l-DOPA, also known as levodopa and l-3,4-dihydroxyphenylalanine, white background
3D image of levodopa skeletal formula - molecular chemical structure of psychoactive drug isolated on white background Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/3d-image-of-levodopa-skeletal-formula-molecular-chemical-structure-of-psychoactive-drug-isolated-on-white-background-image476646510.htmlRF2JKD3DJ–3D image of levodopa skeletal formula - molecular chemical structure of psychoactive drug isolated on white background
Chemical Formula and nomenclature of L-DOPA handwritten with chalk on a blackboard, conceptual image Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/chemical-formula-and-nomenclature-of-l-dopa-handwritten-with-chalk-on-a-blackboard-conceptual-image-image225301334.htmlRFR2FA46–Chemical Formula and nomenclature of L-DOPA handwritten with chalk on a blackboard, conceptual image
Ipswich, UK - 16 April 2022: Sinemet Plus, treatment for Parkinsons disease. Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/ipswich-uk-16-april-2022-sinemet-plus-treatment-for-parkinsons-disease-image467554825.htmlRF2J4JXXH–Ipswich, UK - 16 April 2022: Sinemet Plus, treatment for Parkinsons disease.
3D image of Carbidopa skeletal formula - molecular chemical structure of medication isolated on white background Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/3d-image-of-carbidopa-skeletal-formula-molecular-chemical-structure-of-medication-isolated-on-white-background-image472577481.htmlRF2JCRNB5–3D image of Carbidopa skeletal formula - molecular chemical structure of medication isolated on white background
Levodopa drug Pill Medication ob blue background Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/levodopa-drug-pill-medicationob-blue-background-image476158475.htmlRF2JJJTYR–Levodopa drug Pill Medication ob blue background
L-DOPA (levodopa) Parkinson's disease drug molecule. Skeletal formula. Stock Vectorhttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/l-dopa-levodopa-parkinsons-disease-drug-molecule-skeletal-formula-image457072760.htmlRF2HFHCY4–L-DOPA (levodopa) Parkinson's disease drug molecule. Skeletal formula.
l-DOPA, levodopa molecule. It is an amino acid, is used to increase dopamine concentrations in the treatment of Parkinson's disease. Skeletal chemical Stock Vectorhttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/l-dopa-levodopa-molecule-it-is-an-amino-acid-is-used-to-increase-dopamine-concentrations-in-the-treatment-of-parkinsons-disease-skeletal-chemical-image434138145.htmlRF2G68KHN–l-DOPA, levodopa molecule. It is an amino acid, is used to increase dopamine concentrations in the treatment of Parkinson's disease. Skeletal chemical
The word Restless legs syndrome on the display of a tablet Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/the-word-restless-legs-syndrome-on-the-display-of-a-tablet-image271776075.htmlRFWP4D4B–The word Restless legs syndrome on the display of a tablet
SINEMET RETARD Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/sinemet-retard-image484034234.htmlRF2K3DJGX–SINEMET RETARD
L-DOPA chemical structure on purple background. Stock Vectorhttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/l-dopa-chemical-structure-on-purple-background-image477700524.htmlRF2JN53W0–L-DOPA chemical structure on purple background.
Traditional fava bean soup made with garden vegetables, lac St-Jean, Quebec, Canada Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-traditional-fava-bean-soup-made-with-garden-vegetables-lac-st-jean-81832465.htmlRFEN3P41–Traditional fava bean soup made with garden vegetables, lac St-Jean, Quebec, Canada
Lewy body in parkinson's disease (PD) or dementia (LBD) - closeup 3d illustration Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/lewy-body-in-parkinsons-disease-pd-or-dementia-lbd-closeup-3d-illustration-image455029176.htmlRF2HC8AA0–Lewy body in parkinson's disease (PD) or dementia (LBD) - closeup 3d illustration
Dopaminergic neuron, parkinson's Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/dopaminergic-neuron-parkinsons-image338279484.htmlRM2AJ9XX4–Dopaminergic neuron, parkinson's
3D image of 3,4-Dihydroxyphenylacetic acid skeletal formula - molecular chemical structure of DOPAC isolated on white background Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/3d-image-of-34-dihydroxyphenylacetic-acid-skeletal-formula-molecular-chemical-structure-of-dopac-isolated-on-white-background-image472582947.htmlRF2JCT0AB–3D image of 3,4-Dihydroxyphenylacetic acid skeletal formula - molecular chemical structure of DOPAC isolated on white background
File photo dated 18/01/23 of a general view of staff on a NHS hospital ward at Ealing Hospital in London. NLX-112, a former diabetes trial drug could be used to treat Parkinson's disease within years, research suggests. The drug, designed to treat dyskinesia - involuntary movements that are a common side effect in Parkinson's patients who take levodopa-based medication for several years - could also improve motor symptoms linked to Parkinson's. Issue date: Friday July 7, 2023. Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/file-photo-dated-180123-of-a-general-view-of-staff-on-a-nhs-hospital-ward-at-ealing-hospital-in-london-nlx-112-a-former-diabetes-trial-drug-could-be-used-to-treat-parkinsons-disease-within-years-research-suggests-the-drug-designed-to-treat-dyskinesia-involuntary-movements-that-are-a-common-side-effect-in-parkinsons-patients-who-take-levodopa-based-medication-for-several-years-could-also-improve-motor-symptoms-linked-to-parkinsons-issue-date-friday-july-7-2023-image557562645.htmlRM2RB34RH–File photo dated 18/01/23 of a general view of staff on a NHS hospital ward at Ealing Hospital in London. NLX-112, a former diabetes trial drug could be used to treat Parkinson's disease within years, research suggests. The drug, designed to treat dyskinesia - involuntary movements that are a common side effect in Parkinson's patients who take levodopa-based medication for several years - could also improve motor symptoms linked to Parkinson's. Issue date: Friday July 7, 2023.
Co-Beneldopa (Levodopa / Benserazide) capsules for treating Parkinson's disease Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-co-beneldopa-levodopa-benserazide-capsules-for-treating-parkinsons-38606605.htmlRMC6PK39–Co-Beneldopa (Levodopa / Benserazide) capsules for treating Parkinson's disease
RIO DE JANEIRO, BRAZIL - MARCH 18, 2021: Parkinson's disease medicine (Prolopa - Levodopa + Cloridrato de Benserazida) Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/rio-de-janeiro-brazil-march-18-2021-parkinsons-disease-medicine-prolopa-levodopa-cloridrato-de-benserazida-image467750394.htmlRF2J4YTB6–RIO DE JANEIRO, BRAZIL - MARCH 18, 2021: Parkinson's disease medicine (Prolopa - Levodopa + Cloridrato de Benserazida)
Levodopa (L-DOPA) Parkinson's disease drug molecular model L-DOPA is a precursor of the catecholamine neurotransmitters Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/levodopa-l-dopa-parkinsons-disease-drug-molecular-model-l-dopa-is-image69886281.htmlRFE1KGJH–Levodopa (L-DOPA) Parkinson's disease drug molecular model L-DOPA is a precursor of the catecholamine neurotransmitters
RIO DE JANEIRO, BRAZIL - MARCH 18, 2021: Parkinson's disease medicine (Prolopa - Levodopa + Cloridrato de Benserazida) Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/rio-de-janeiro-brazil-march-18-2021-parkinsons-disease-medicine-prolopa-levodopa-cloridrato-de-benserazida-image467750342.htmlRF2J4YT9A–RIO DE JANEIRO, BRAZIL - MARCH 18, 2021: Parkinson's disease medicine (Prolopa - Levodopa + Cloridrato de Benserazida)
stalevo 150 tablet Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stalevo-150-tablet-image464834521.htmlRM2J0714W–stalevo 150 tablet
Carbidopa is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism of levodopa Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/carbidopa-is-a-drug-given-to-people-with-parkinsons-disease-in-order-to-inhibit-peripheral-metabolism-of-levodopa-image353699466.htmlRF2BFCB7P–Carbidopa is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism of levodopa
PD (Parkinson’s Disease) wooden cubes on grey background Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/pd-parkinsons-disease-wooden-cubes-on-grey-background-image556293245.htmlRF2R919KW–PD (Parkinson’s Disease) wooden cubes on grey background
FDA 101: Smoking Cessation Products Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-fda-101-smoking-cessation-products-54555685.htmlRMD4N699–FDA 101: Smoking Cessation Products
Levodopa white medical pills and tablets spilling out of a drug bottle. Macro top down view with copy space. Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/levodopa-white-medical-pills-and-tablets-spilling-out-of-a-drug-bottle-macro-top-down-view-with-copy-space-image476158436.htmlRF2JJJTXC–Levodopa white medical pills and tablets spilling out of a drug bottle. Macro top down view with copy space.
L-DOPA (levodopa) Parkinson's disease drug molecule. Skeletal formula. Stock Vectorhttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/l-dopa-levodopa-parkinsons-disease-drug-molecule-skeletal-formula-image457073104.htmlRF2HFHDBC–L-DOPA (levodopa) Parkinson's disease drug molecule. Skeletal formula.
l-DOPA, levodopa molecule. It is an amino acid, is used to increase dopamine concentrations in the treatment of Parkinson's disease. Structural chemic Stock Vectorhttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/l-dopa-levodopa-molecule-it-is-an-amino-acid-is-used-to-increase-dopamine-concentrations-in-the-treatment-of-parkinsons-disease-structural-chemic-image434138161.htmlRF2G68KJ9–l-DOPA, levodopa molecule. It is an amino acid, is used to increase dopamine concentrations in the treatment of Parkinson's disease. Structural chemic
L-DOPA (levodopa) Parkinson's disease drug molecule. Skeletal formula. Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-image-l-dopa-levodopa-parkinsons-disease-drug-molecule-skeletal-formula-165809933.htmlRFKHN879–L-DOPA (levodopa) Parkinson's disease drug molecule. Skeletal formula.
l-DOPA, levodopa molecule. It is an amino acid, is used to increase dopamine concentrations in the treatment of Parkinson's disease. Molecular model. Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/l-dopa-levodopa-molecule-it-is-an-amino-acid-is-used-to-increase-dopamine-concentrations-in-the-treatment-of-parkinsons-disease-molecular-model-image413355718.htmlRF2F0DYC6–l-DOPA, levodopa molecule. It is an amino acid, is used to increase dopamine concentrations in the treatment of Parkinson's disease. Molecular model.
L-DOPA (levodopa) Parkinson's disease drug molecule. Skeletal formula. Stock Vectorhttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-image-l-dopa-levodopa-parkinsons-disease-drug-molecule-skeletal-formula-165796231.htmlRFKHMJNY–L-DOPA (levodopa) Parkinson's disease drug molecule. Skeletal formula.
l-DOPA, levodopa molecule. It is an amino acid, is used to increase dopamine concentrations in the treatment of Parkinson's disease. Molecular model. Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/l-dopa-levodopa-molecule-it-is-an-amino-acid-is-used-to-increase-dopamine-concentrations-in-the-treatment-of-parkinsons-disease-molecular-model-image413355709.htmlRF2F0DYBW–l-DOPA, levodopa molecule. It is an amino acid, is used to increase dopamine concentrations in the treatment of Parkinson's disease. Molecular model.
Carbidopa Parkinson's Disease drug. Prevents peripheral breakdown of levodopa, allowing more L-DOPA to reach the brain. Conventi Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-carbidopa-parkinsons-disease-drug-prevents-peripheral-breakdown-of-73403617.htmlRFE7BR1N–Carbidopa Parkinson's Disease drug. Prevents peripheral breakdown of levodopa, allowing more L-DOPA to reach the brain. Conventi
l-DOPA, levodopa molecule. It is an amino acid, is used to increase dopamine concentrations in the treatment of Parkinson's disease. Dark blue backgro Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/l-dopa-levodopa-molecule-it-is-an-amino-acid-is-used-to-increase-dopamine-concentrations-in-the-treatment-of-parkinsons-disease-dark-blue-backgro-image434138099.htmlRF2G68KG3–l-DOPA, levodopa molecule. It is an amino acid, is used to increase dopamine concentrations in the treatment of Parkinson's disease. Dark blue backgro
L-DOPA (levodopa) Parkinson's disease drug molecule. Atoms are represented as spheres with conventional color coding: hydrogen ( Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-l-dopa-levodopa-parkinsons-disease-drug-molecule-atoms-are-represented-74623913.htmlRFE9BBFN–L-DOPA (levodopa) Parkinson's disease drug molecule. Atoms are represented as spheres with conventional color coding: hydrogen (
l-DOPA, levodopa molecule. It is an amino acid, is used to increase dopamine concentrations in the treatment of Parkinson's disease. Paper packaging f Stock Vectorhttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/l-dopa-levodopa-molecule-it-is-an-amino-acid-is-used-to-increase-dopamine-concentrations-in-the-treatment-of-parkinsons-disease-paper-packaging-f-image434138155.htmlRF2G68KJ3–l-DOPA, levodopa molecule. It is an amino acid, is used to increase dopamine concentrations in the treatment of Parkinson's disease. Paper packaging f
Co-Beneldopa (Levodopa / Benserazide) capsules for treating Parkinson's disease Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-co-beneldopa-levodopa-benserazide-capsules-for-treating-parkinsons-38606597.htmlRMC6PK31–Co-Beneldopa (Levodopa / Benserazide) capsules for treating Parkinson's disease
SINEMET RETARD Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/sinemet-retard-image484034232.htmlRF2K3DJGT–SINEMET RETARD
Levodopa (L-DOPA) Parkinson's disease drug molecular model L-DOPA is a precursor of the catecholamine neurotransmitters Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/levodopa-l-dopa-parkinsons-disease-drug-molecular-model-l-dopa-is-image69886285.htmlRFE1KGJN–Levodopa (L-DOPA) Parkinson's disease drug molecular model L-DOPA is a precursor of the catecholamine neurotransmitters
RIO DE JANEIRO, BRAZIL - MARCH 18, 2021: Parkinson's disease medicine (Prolopa - Levodopa + Cloridrato de Benserazida) Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/rio-de-janeiro-brazil-march-18-2021-parkinsons-disease-medicine-prolopa-levodopa-cloridrato-de-benserazida-image467750329.htmlRF2J4YT8W–RIO DE JANEIRO, BRAZIL - MARCH 18, 2021: Parkinson's disease medicine (Prolopa - Levodopa + Cloridrato de Benserazida)
Computer illustration of a ball and stick model of a levodopa molecule. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (black), oxygen (red) and nitrogen (blue). Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/computer-illustration-of-a-ball-and-stick-model-of-a-levodopa-molecule-atoms-are-represented-as-spheres-and-are-colour-coded-hydrogen-white-carbon-black-oxygen-red-and-nitrogen-blue-image628777624.htmlRF2YEY87M–Computer illustration of a ball and stick model of a levodopa molecule. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (black), oxygen (red) and nitrogen (blue).
Traditional fava bean soup made with garden vegetables, lac St-Jean, Quebec, Canada Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-traditional-fava-bean-soup-made-with-garden-vegetables-lac-st-jean-81833886.htmlRFEN3RXP–Traditional fava bean soup made with garden vegetables, lac St-Jean, Quebec, Canada
Levodopa. Molecular model of the drug levodopa (C9.H11.N.O4), also known as L-DOPA (L-3, 4-dihydroxyphenylalanine). This drug is used in the treatment of Parkinson's disease and dopamine-responsive dystonia. Atoms are represented as spheres and are colour-coded: carbon (grey), hydrogen (white), nitrogen (blue) and oxygen (red). Illustration. Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-levodopa-molecular-model-of-the-drug-levodopa-c9h11no4-also-known-126900066.htmlRFHACP96–Levodopa. Molecular model of the drug levodopa (C9.H11.N.O4), also known as L-DOPA (L-3, 4-dihydroxyphenylalanine). This drug is used in the treatment of Parkinson's disease and dopamine-responsive dystonia. Atoms are represented as spheres and are colour-coded: carbon (grey), hydrogen (white), nitrogen (blue) and oxygen (red). Illustration.
Dopamine metabolism MAO (monoamine oxidase) pathway - biotransformation of Tyrosine to L-DOPA, Dopamine and DOPAC. Pink background infographic. Stock Vectorhttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/dopamine-metabolism-mao-monoamine-oxidase-pathway-biotransformation-of-tyrosine-to-l-dopa-dopamine-and-dopac-pink-background-infographic-image477700398.htmlRF2JN53ME–Dopamine metabolism MAO (monoamine oxidase) pathway - biotransformation of Tyrosine to L-DOPA, Dopamine and DOPAC. Pink background infographic.
Lewy bodies in parkinson's disease (PD) or dementia (LBD) - isometric 3d illustration Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/lewy-bodies-in-parkinsons-disease-pd-or-dementia-lbd-isometric-3d-illustration-image455029177.htmlRF2HC8AA1–Lewy bodies in parkinson's disease (PD) or dementia (LBD) - isometric 3d illustration
Dopaminergic neuron, parkinson's Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/dopaminergic-neuron-parkinsons-image338279493.htmlRM2AJ9XXD–Dopaminergic neuron, parkinson's
stalevo 50 tablet Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stalevo-50-tablet-image464834512.htmlRM2J0714G–stalevo 50 tablet
Carbidopa is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism of levodopa Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/carbidopa-is-a-drug-given-to-people-with-parkinsons-disease-in-order-to-inhibit-peripheral-metabolism-of-levodopa-image353699472.htmlRF2BFCB80–Carbidopa is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism of levodopa
Levodopa is a medication used to treat Parkinson's disease. It is available in the form of tablets and capsules. The dosage form and strength depend o Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/levodopa-is-a-medication-used-to-treat-parkinsons-disease-it-is-available-in-the-form-of-tablets-and-capsules-the-dosage-form-and-strength-depend-o-image563882089.htmlRF2RNB1A1–Levodopa is a medication used to treat Parkinson's disease. It is available in the form of tablets and capsules. The dosage form and strength depend o
Lewy body in parkinson's disease (PD) or dementia (LBD) - isometric 3d illustration Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/lewy-body-in-parkinsons-disease-pd-or-dementia-lbd-isometric-3d-illustration-image456010474.htmlRF2HDW20A–Lewy body in parkinson's disease (PD) or dementia (LBD) - isometric 3d illustration
L-DOPA (levodopa) Parkinson's disease drug molecule. Atoms are represented as spheres with conventional color coding: hydrogen ( Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-l-dopa-levodopa-parkinsons-disease-drug-molecule-atoms-are-represented-74623919.htmlRFE9BBFY–L-DOPA (levodopa) Parkinson's disease drug molecule. Atoms are represented as spheres with conventional color coding: hydrogen (
l-DOPA, levodopa molecule. It is an amino acid, is used to increase dopamine concentrations in the treatment of Parkinson's disease. Sheet of paper in Stock Vectorhttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/l-dopa-levodopa-molecule-it-is-an-amino-acid-is-used-to-increase-dopamine-concentrations-in-the-treatment-of-parkinsons-disease-sheet-of-paper-in-image434138131.htmlRF2G68KH7–l-DOPA, levodopa molecule. It is an amino acid, is used to increase dopamine concentrations in the treatment of Parkinson's disease. Sheet of paper in
Co-Beneldopa (Levodopa / Benserazide) capsules for treating Parkinson's disease Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-co-beneldopa-levodopa-benserazide-capsules-for-treating-parkinsons-38606602.htmlRMC6PK36–Co-Beneldopa (Levodopa / Benserazide) capsules for treating Parkinson's disease
SINEMET RETARD Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/sinemet-retard-image484034233.htmlRF2K3DJGW–SINEMET RETARD
Co-Beneldopa (Levodopa / Benserazide) capsules for treating Parkinson's disease Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-co-beneldopa-levodopa-benserazide-capsules-for-treating-parkinsons-38606587.htmlRMC6PK2K–Co-Beneldopa (Levodopa / Benserazide) capsules for treating Parkinson's disease
Traditional fava bean soup made with garden vegetables, lac St-Jean, Quebec, Canada Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-traditional-fava-bean-soup-made-with-garden-vegetables-lac-st-jean-81832468.htmlRFEN3P44–Traditional fava bean soup made with garden vegetables, lac St-Jean, Quebec, Canada
Levodopa. Molecular model of the drug levodopa (C9.H11.N.O4), also known as L-DOPA (L-3, 4-dihydroxyphenylalanine). This drug is used in the treatment of Parkinson's disease and dopamine-responsive dystonia. Atoms are represented as spheres and are colour-coded: carbon (grey), hydrogen (white), nitrogen (blue) and oxygen (red). Illustration. Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-levodopa-molecular-model-of-the-drug-levodopa-c9h11no4-also-known-126899404.htmlRFHACNDG–Levodopa. Molecular model of the drug levodopa (C9.H11.N.O4), also known as L-DOPA (L-3, 4-dihydroxyphenylalanine). This drug is used in the treatment of Parkinson's disease and dopamine-responsive dystonia. Atoms are represented as spheres and are colour-coded: carbon (grey), hydrogen (white), nitrogen (blue) and oxygen (red). Illustration.
Dopamine neurotransmitter chemical structure on white background. Stock Vectorhttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/dopamine-neurotransmitter-chemical-structure-on-white-background-image477699973.htmlRF2JN5359–Dopamine neurotransmitter chemical structure on white background.
Levodopa (L-DOPA) drug molecule Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-levodopa-l-dopa-drug-molecule-47691958.htmlRFCNGFG6–Levodopa (L-DOPA) drug molecule
Parkinson disease Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/parkinson-disease-image338277722.htmlRM2AJ9TK6–Parkinson disease
Levodopa (L-DOPA) drug molecule Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-levodopa-l-dopa-drug-molecule-47685863.htmlRFCNG7PF–Levodopa (L-DOPA) drug molecule
stalevo 100 tablet Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stalevo-100-tablet-image464834515.htmlRM2J0714K–stalevo 100 tablet
Carbidopa is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism of levodopa Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/carbidopa-is-a-drug-given-to-people-with-parkinsons-disease-in-order-to-inhibit-peripheral-metabolism-of-levodopa-image353699482.htmlRF2BFCB8A–Carbidopa is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism of levodopa
madopar '250' capsules Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/madopar-250-capsules-image464834389.htmlRM2J07105–madopar '250' capsules
Lewy body in parkinson's disease (PD) or dementia (LBD) - isomteric 3d illustration Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/lewy-body-in-parkinsons-disease-pd-or-dementia-lbd-isomteric-3d-illustration-image455029182.htmlRF2HC8AA6–Lewy body in parkinson's disease (PD) or dementia (LBD) - isomteric 3d illustration
L-DOPA (levodopa) Parkinson's disease drug molecule. Atoms are represented as spheres with conventional color coding: hydrogen ( Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-l-dopa-levodopa-parkinsons-disease-drug-molecule-atoms-are-represented-74623911.htmlRFE9BBFK–L-DOPA (levodopa) Parkinson's disease drug molecule. Atoms are represented as spheres with conventional color coding: hydrogen (
l-DOPA, levodopa molecule. It is an amino acid, is used to increase dopamine concentrations in the treatment of Parkinson's disease. Dark blue backgro Stock Vectorhttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/l-dopa-levodopa-molecule-it-is-an-amino-acid-is-used-to-increase-dopamine-concentrations-in-the-treatment-of-parkinsons-disease-dark-blue-backgro-image434138134.htmlRF2G68KHA–l-DOPA, levodopa molecule. It is an amino acid, is used to increase dopamine concentrations in the treatment of Parkinson's disease. Dark blue backgro
Carbidopa Parkinson's Disease drug. Prevents peripheral breakdown of levodopa, allowing more L-DOPA to reach the brain. Skeletal formula. Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-image-carbidopa-parkinsons-disease-drug-prevents-peripheral-breakdown-of-165809540.htmlRFKHN7N8–Carbidopa Parkinson's Disease drug. Prevents peripheral breakdown of levodopa, allowing more L-DOPA to reach the brain. Skeletal formula.
SINEMET RETARD Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/sinemet-retard-image484034235.htmlRF2K3DJGY–SINEMET RETARD
Carbidopa Parkinson's Disease drug. Prevents peripheral breakdown of levodopa, allowing more L-DOPA to reach the brain. Skeletal formula. Stock Vectorhttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-image-carbidopa-parkinsons-disease-drug-prevents-peripheral-breakdown-of-165796048.htmlRFKHMJFC–Carbidopa Parkinson's Disease drug. Prevents peripheral breakdown of levodopa, allowing more L-DOPA to reach the brain. Skeletal formula.
Carbidopa molecule. It is dopa decarboxylase inhibitor used for treatment of idiopathic Parkinson disease. Molecular model. 3D rendering. Illustration Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/carbidopa-molecule-it-is-dopa-decarboxylase-inhibitor-used-for-treatment-of-idiopathic-parkinson-disease-molecular-model-3d-rendering-illustration-image475073893.htmlRF2JGWDGN–Carbidopa molecule. It is dopa decarboxylase inhibitor used for treatment of idiopathic Parkinson disease. Molecular model. 3D rendering. Illustration
Carbidopa Parkinson's Disease drug. Prevents peripheral breakdown of levodopa, allowing more L-DOPA to reach the brain. Skeletal formula. Stock Vectorhttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/carbidopa-parkinsons-disease-drug-prevents-peripheral-breakdown-of-levodopa-allowing-more-l-dopa-to-reach-the-brain-skeletal-formula-image457084815.htmlRF2HFJ09K–Carbidopa Parkinson's Disease drug. Prevents peripheral breakdown of levodopa, allowing more L-DOPA to reach the brain. Skeletal formula.
Traditional fava bean soup made with garden vegetables, lac St-Jean, Quebec, Canada Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-traditional-fava-bean-soup-made-with-garden-vegetables-lac-st-jean-81832472.htmlRFEN3P48–Traditional fava bean soup made with garden vegetables, lac St-Jean, Quebec, Canada
Carbidopa molecule. It is dopa decarboxylase inhibitor used for treatment of idiopathic Parkinson disease. Molecular model. 3D rendering. Illustration Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/carbidopa-molecule-it-is-dopa-decarboxylase-inhibitor-used-for-treatment-of-idiopathic-parkinson-disease-molecular-model-3d-rendering-illustration-image475073898.htmlRF2JGWDGX–Carbidopa molecule. It is dopa decarboxylase inhibitor used for treatment of idiopathic Parkinson disease. Molecular model. 3D rendering. Illustration
Dopamine metabolism MAO (monoamine oxidase) pathway - biotransformation of Tyrosine to L-DOPA, Dopamine and DOPAC. Purple background infographic. Stock Vectorhttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/dopamine-metabolism-mao-monoamine-oxidase-pathway-biotransformation-of-tyrosine-to-l-dopa-dopamine-and-dopac-purple-background-infographic-image477700089.htmlRF2JN539D–Dopamine metabolism MAO (monoamine oxidase) pathway - biotransformation of Tyrosine to L-DOPA, Dopamine and DOPAC. Purple background infographic.
Carbidopa molecule. It is dopa decarboxylase inhibitor used for treatment of idiopathic Parkinson disease. Structural chemical formula, molecule model Stock Vectorhttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/carbidopa-molecule-it-is-dopa-decarboxylase-inhibitor-used-for-treatment-of-idiopathic-parkinson-disease-structural-chemical-formula-molecule-model-image566039379.htmlRF2RTW903–Carbidopa molecule. It is dopa decarboxylase inhibitor used for treatment of idiopathic Parkinson disease. Structural chemical formula, molecule model
Levodopa (L-DOPA) drug molecule Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-levodopa-l-dopa-drug-molecule-47684025.htmlRFCNG5CW–Levodopa (L-DOPA) drug molecule
Levodopa (L-DOPA) drug molecule Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-levodopa-l-dopa-drug-molecule-47682770.htmlRFCNG3T2–Levodopa (L-DOPA) drug molecule
sinemet 521 tablet Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/sinemet-521-tablet-image464834500.htmlRM2J07144–sinemet 521 tablet
Levodopa Parkinson's disease drug Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/levodopa-parkinsons-disease-drug-image65216158.htmlRFDP2RTE–Levodopa Parkinson's disease drug
Carbidopa is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism of levodopa Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/carbidopa-is-a-drug-given-to-people-with-parkinsons-disease-in-order-to-inhibit-peripheral-metabolism-of-levodopa-image353699475.htmlRF2BFCB83–Carbidopa is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism of levodopa
SINEMET RETARD Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/sinemet-retard-image484034239.htmlRF2K3DJH3–SINEMET RETARD
Carbidopa Parkinson's Disease drug. Prevents peripheral breakdown of levodopa, allowing more L-DOPA to reach the brain. Skeletal formula. Stock Vectorhttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/carbidopa-parkinsons-disease-drug-prevents-peripheral-breakdown-of-levodopa-allowing-more-l-dopa-to-reach-the-brain-skeletal-formula-image457078145.htmlRF2HFHKRD–Carbidopa Parkinson's Disease drug. Prevents peripheral breakdown of levodopa, allowing more L-DOPA to reach the brain. Skeletal formula.
Carbidopa Parkinson's Disease drug. Prevents peripheral breakdown of levodopa, allowing more L-DOPA to reach the brain. Atoms ar Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-carbidopa-parkinsons-disease-drug-prevents-peripheral-breakdown-of-73585907.htmlRFE7M3G3–Carbidopa Parkinson's Disease drug. Prevents peripheral breakdown of levodopa, allowing more L-DOPA to reach the brain. Atoms ar
DOPAC chemical structure on purple background. Stock Vectorhttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/dopac-chemical-structure-on-purple-background-image477700013.htmlRF2JN536N–DOPAC chemical structure on purple background.
Carbidopa molecule. It is dopa decarboxylase inhibitor used for treatment of idiopathic Parkinson disease. Skeletal chemical formula. Paper packaging Stock Vectorhttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/carbidopa-molecule-it-is-dopa-decarboxylase-inhibitor-used-for-treatment-of-idiopathic-parkinson-disease-skeletal-chemical-formula-paper-packaging-image566039456.htmlRF2RTW92T–Carbidopa molecule. It is dopa decarboxylase inhibitor used for treatment of idiopathic Parkinson disease. Skeletal chemical formula. Paper packaging
madopar 125 tablet Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/madopar-125-tablet-image464834392.htmlRM2J07108–madopar 125 tablet
Levodopa Parkinson's disease drug Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/levodopa-parkinsons-disease-drug-image65216157.htmlRFDP2RTD–Levodopa Parkinson's disease drug
Carbidopa is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism of levodopa Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/carbidopa-is-a-drug-given-to-people-with-parkinsons-disease-in-order-to-inhibit-peripheral-metabolism-of-levodopa-image353699467.htmlRF2BFCB7R–Carbidopa is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism of levodopa
SINEMET RETARD Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/sinemet-retard-image484034237.htmlRF2K3DJH1–SINEMET RETARD
Carbidopa Parkinson's Disease drug. Prevents peripheral breakdown of levodopa, allowing more L-DOPA to reach the brain. Atoms ar Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-carbidopa-parkinsons-disease-drug-prevents-peripheral-breakdown-of-73585906.htmlRFE7M3G2–Carbidopa Parkinson's Disease drug. Prevents peripheral breakdown of levodopa, allowing more L-DOPA to reach the brain. Atoms ar
Dopamine neurotransmitter chemical structure on purple background. Stock Vectorhttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/dopamine-neurotransmitter-chemical-structure-on-purple-background-image477699063.htmlRF2JN520R–Dopamine neurotransmitter chemical structure on purple background.
Carbidopa molecule. It is dopa decarboxylase inhibitor used for treatment of idiopathic Parkinson disease. Structural chemical formula on the dark blu Stock Vectorhttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/carbidopa-molecule-it-is-dopa-decarboxylase-inhibitor-used-for-treatment-of-idiopathic-parkinson-disease-structural-chemical-formula-on-the-dark-blu-image566039894.htmlRF2RTW9JE–Carbidopa molecule. It is dopa decarboxylase inhibitor used for treatment of idiopathic Parkinson disease. Structural chemical formula on the dark blu
half sinemet - CR Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/half-sinemet-cr-image464834377.htmlRM2J070YN–half sinemet - CR
Levodopa Parkinson's disease drug Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/levodopa-parkinsons-disease-drug-image65216156.htmlRFDP2RTC–Levodopa Parkinson's disease drug
Carbidopa is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism of levodopa Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/carbidopa-is-a-drug-given-to-people-with-parkinsons-disease-in-order-to-inhibit-peripheral-metabolism-of-levodopa-image353699485.htmlRF2BFCB8D–Carbidopa is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism of levodopa
L-DOPA (levodopa) Parkinson's disease drug molecule. Blue skeletal formula on white background. Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/l-dopa-levodopa-parkinsons-disease-drug-molecule-blue-skeletal-formula-on-white-background-image248005876.htmlRFTBDJ0M–L-DOPA (levodopa) Parkinson's disease drug molecule. Blue skeletal formula on white background.
L-DOPA (levodopa) Parkinson's disease drug molecule Stylized skeletal formula (chemical structure) Atoms are shown as Stock Photohttps://www.alamy.com/image-license-details/?v=1https://www.alamy.com/stock-photo-l-dopa-levodopa-parkinsons-disease-drug-molecule-stylized-skeletal-101778033.htmlRFFWGAWN–L-DOPA (levodopa) Parkinson's disease drug molecule Stylized skeletal formula (chemical structure) Atoms are shown as
